| Symbol |
Name |
|
APOBEC1
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CHEK2
|
checkpoint kinase 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
DCUN1D3
|
DCN1, defective in cullin neddylation 1, domain containing 3
|
|
DDIAS
|
DNA damage-induced apoptosis suppressor
|
|
EGR1
|
early growth response 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
GATA3
|
GATA binding protein 3
|
|
GPX1
|
glutathione peroxidase 1
|
|
GTF2H5
|
general transcription factor IIH, polypeptide 5
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NOX4
|
NADPH oxidase 4
|
|
PML
|
promyelocytic leukemia
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
TIGAR
|
TP53 induced glycolysis regulatory phosphatase
|
|
TLK2
|
tousled-like kinase 2
|
|
TMEM109
|
transmembrane protein 109
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TRIM13
|
tripartite motif containing 13
|
|
TSPYL5
|
TSPY-like 5
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
YAP1
|
Yes-associated protein 1
|
